From: The tuberculosis challenge in a rural South African HIV programme
Variable | Prevalent TB n(%) | No Prevalent TB n(%) | Unadjusted OR (95%CI) | Adjusted OR (95%CI) |
---|---|---|---|---|
Sex | ||||
Female | 136 (68.7) | 413 (70.5) | REF | |
Male | 62 (31.3) | 172 (29.5) | 1.09 (0.77-1.54) | |
Age (yrs) | 35 (IQR 30-42) | 37 (IQR 31-44) | 0.98 (0.97-1.00) | 0.99 (0.97-1.01) |
Transfer in | ||||
No | 192 (97.0) | 563 (96.1) | REF | |
Yes | 6 (3.0) | 23 (3.9) | 0.76 (0.31-1.91) | |
CD4 at initiation | 88 [IQR 30-153] | 129 [IQR 71-179] | ||
>200 | REF | REF | ||
50-200 | 1.30 (0.80-2.10) | 1.03 (0.58-1.86) | ||
<50 | 3.22 (1.88-5.51) | 2.61 (1.36-5.03) | ||
Baseline RNA VL (log 10 ) | 4.91 | 4.70 | 1.26 (1.01-1.58) | 1.23(0.99-1.54) |
Prior TB | ||||
No | 113 (57.1) | 387 (66.0) | REF | REF |
Yes | 85 (42.9) | 199 (34.0) | 1.46 (1.05-2.03) | 1.58 (1.06-2.36) |
WHO Stage | ||||
1 or 2 | N/A | 214 (36.5) | N/A | N/A |
3 or 4 | 198 (100) | 282 (48.1) | N/A | N/A |
Unknown | N/A | 90 (15.4) | N/A | N/A |